Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Axsome Therapeutics, Inc. - SIC # 2830 -
Ticker
Exchange
SIC #
Website
Latest Ticker
AXSM
Nasdaq
2830
www.axsome.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Axsome Therapeutics, Inc.
Revenue Growth And Narrower Losses Could Change The Case For Axsome Therapeutics Stock
- Nov 2nd, 2026 6:22 pm
Axsome Therapeutics Inc (AXSM) (Q3 2026) Earnings Call Highlights: Revenue Tops $1 Billion Run ...
- Nov 2nd, 2026 6:02 pm
AXSM Stock Hits Fresh 52-Week Lows As Launch Concerns Of Auvelity In Alzheimer's Care Outweigh Q3 Beat
- Nov 2nd, 2026 4:32 pm
Earnings Calendar and Analysis for This Week
- Nov 2nd, 2026 3:19 pm
Axsome Sinks 10% Despite Q3 Revenue Beat “Surpassing a One-Billion-Dollar Annual Run Rate”
- Nov 2nd, 2026 11:56 am
Axsome Therapeutics, Inc. Q3 2026 Earnings Call Summary
- Nov 2nd, 2026 10:55 am
Axsome (AXSM) Q3 2026 Earnings Call Transcript
- Nov 2nd, 2026 9:58 am
What Axsome Therapeutics (AXSM) Said on Its Q3 Earnings Call
- Nov 2nd, 2026 9:13 am
Axsome (AXSM) Reports Q3 Earnings: What Key Metrics Have to Say
- Nov 2nd, 2026 6:30 am
Axsome Therapeutics Shares Rise 2.13% as Q3 Revenue Jumps 52% and Loss Narrows
- Nov 2nd, 2026 6:29 am
Axsome Therapeutics (AXSM) Reports Q3 Loss, Tops Revenue Estimates
- Nov 2nd, 2026 5:15 am
Axsome: Q3 Earnings Snapshot
- Nov 2nd, 2026 5:08 am
Axsome Therapeutics Reports Third Quarter 2026 Financial Results and Provides Business Update
- Nov 2nd, 2026 5:00 am
Could Axsome Therapeutics Turn $5,000 Into $50,000 by 2035?
- Oct 29th, 2026 12:20 pm
Axsome Therapeutics vs. Moderna: Consistent Revenue Growth or Sharp Volatility
- Oct 28th, 2026 7:44 am
Rhythm Pharmaceuticals, Inc. (RYTM) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release
- Oct 27th, 2026 7:00 am
Will Axsome Therapeutics (AXSM) Report Negative Earnings Next Week? What You Should Know
- Oct 26th, 2026 7:00 am
2 Growth Stocks to Hold for the Next Decade (Hint: These Aren’t AI Stocks)
- Oct 23rd, 2026 2:05 pm
Will Auvelity Continue to Aid Axsome's Top-Line Growth in Q3?
- Oct 21st, 2026 8:00 am
Scroll